How is Prolia (denosumab) given?
Prolia is administered as a single injection under the skin (subcutaneous). It is typically given in the upper arm, thigh, or abdomen. [1][2]
What dose schedule is used for Prolia?
The standard dosing is 60 mg injected subcutaneously every 6 months. [1][2]
Who should give the injection, and can it be self-administered?
Prolia is prescribed for patients who are able to receive the medication by injection. The injection can be given by a healthcare professional, and depending on the product instructions provided to you and local practice, some patients are taught to inject it themselves. Follow the exact instructions given by your prescriber or the packaging label for your specific product. [1][2]
What should be done before each dose?
Before giving Prolia, clinicians typically check calcium status and correct low calcium if needed, because Prolia can lower blood calcium. Adequate calcium and vitamin D intake is also commonly recommended as part of the regimen. [1]
What side effects and risks should be watched after administration?
Patients are commonly monitored for symptoms of low calcium (such as muscle cramps, spasms, tingling in the fingers/toes, or lightheadedness) and for signs of infection. If you develop these symptoms or have concerns after your injection, contact your clinician promptly. [1]
What if a dose is missed?
Prolia is dosed every 6 months. If you miss a scheduled dose, contact your prescriber for guidance on when to take the next injection so your dosing interval stays as consistent as possible. [1]
Are there differences between Prolia and Xgeva administration?
Prolia and Xgeva both contain denosumab, but they are used for different indications and dosing schedules. Your prescribing information for Prolia specifically should guide the frequency and injection method for your case. [2]
Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125320s179lbl.pdf
[2] https://www.ema.europa.eu/en/medicines/human/EPAR/prolia